169 related articles for article (PubMed ID: 23988697)
1. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus.
Bhomia M; Sharma A; Gayen M; Gupta P; Maheshwari RK
Antiviral Res; 2013 Nov; 100(2):429-34. PubMed ID: 23988697
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
[TBL] [Abstract][Full Text] [Related]
4. Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.
Bakovic A; Bhalla N; Kortchak S; Sun C; Zhou W; Ahmed A; Risner K; Klimstra WB; Narayanan A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933112
[TBL] [Abstract][Full Text] [Related]
5. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
[TBL] [Abstract][Full Text] [Related]
6. Hypervariable domain of nonstructural protein nsP3 of Venezuelan equine encephalitis virus determines cell-specific mode of virus replication.
Foy NJ; Akhrymuk M; Shustov AV; Frolova EI; Frolov I
J Virol; 2013 Jul; 87(13):7569-84. PubMed ID: 23637407
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A
Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592
[TBL] [Abstract][Full Text] [Related]
8. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
9. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
Sharma A; Knollmann-Ritschel B
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
[TBL] [Abstract][Full Text] [Related]
11. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH
Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
Carey BD; Ammosova T; Pinkham C; Lin X; Zhou W; Liotta LA; Nekhai S; Kehn-Hall K
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769351
[TBL] [Abstract][Full Text] [Related]
13. Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain.
Bhomia M; Balakathiresan N; Sharma A; Gupta P; Biswas R; Maheshwari R
Biochem Biophys Res Commun; 2010 Apr; 395(1):11-6. PubMed ID: 20303929
[TBL] [Abstract][Full Text] [Related]
14. Emergence and Magnitude of ML336 Resistance in Venezuelan Equine Encephalitis Virus Depend on the Microenvironment.
Lee J; Parvathareddy J; Yang D; Bansal S; O'Connell K; Golden JE; Jonsson CB
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878897
[TBL] [Abstract][Full Text] [Related]
15. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production.
Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K
Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
[TBL] [Abstract][Full Text] [Related]
17. The role of IKKβ in Venezuelan equine encephalitis virus infection.
Amaya M; Voss K; Sampey G; Senina S; de la Fuente C; Mueller C; Calvert V; Kehn-Hall K; Carpenter C; Kashanchi F; Bailey C; Mogelsvang S; Petricoin E; Narayanan A
PLoS One; 2014; 9(2):e86745. PubMed ID: 24586253
[TBL] [Abstract][Full Text] [Related]
18. Mutations in Hypervariable Domain of Venezuelan Equine Encephalitis Virus nsP3 Protein Differentially Affect Viral Replication.
Meshram CD; Phillips AT; Lukash T; Shiliaev N; Frolova EI; Frolov I
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694937
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses.
Yin J; Gardner CL; Burke CW; Ryman KD; Klimstra WB
J Virol; 2009 Oct; 83(19):10036-47. PubMed ID: 19641001
[TBL] [Abstract][Full Text] [Related]
20. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.
Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I
J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
